Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

Fetal gene therapy on the horizon?

06 April 2004

By Dr Jess Buxton

Appeared in BioNews 252

Doctors may one day be able to use gene therapy to treat fetuses affected by genetic conditions, say UK scientists. Researchers at Imperial College, University College and the Royal Free Hospital, all in London, have successfully used gene therapy to treat unborn mice affected by haemophilia B. Simon Waddington, of Imperial College, presented the team's results at the first annual meeting of the British Society for Gene Therapy, held in Oxford this week. The scientists now plan to assess the safety and ethical issues associated with using the technique in humans, according to a report in the Daily Telegraph newspaper.

People with haemophilia, nearly always boys, bruise easily and bleed for longer if they injure themselves. Haemophilia B is caused by a missing or faulty version of an X chromosome gene, which makes a crucial blood clotting protein called Factor IX. Dr Waddington and colleagues used an adapted version of the human immunodeficiency virus (HIV), altered so that it can no longer cause disease, to deliver a working copy of the Factor IX gene to mouse fetuses with haemophilia B. Waddington said that gene therapy in the womb (in utero) was now advancing to where it could be considered on patients in special circumstances. He cited cases where a genetic disorder is diagnosed during pregnancy, but where the parents do not wish to terminate the pregnancy, for religious or personal reasons. Charles Rodeck, of University College, went further, saying that fetal gene therapy could provide another option for affected families, apart from terminating or continuing with an untreated pregnancy. 'We would like this to be a third option - perhaps the best option' he said.

Professor Charles Coutelle, head of the gene therapy research group at Imperial College, said that it would be years before human fetal gene therapy trials could be considered. But if the approach is shown to be safe and efficient in larger animals, such as sheep, then it could offer hope for new treatments for diseases such as muscular dystrophy and cystic fibrosis. It is thought that fetal gene therapy might be more successful than treating children, since it would be easier to target more of the affected tissue, and there would be less chance of serious immune reactions.

A spokesperson for the Department of Health said that the researchers would need permission from both the Gene Therapy Advisory Committee (GTAC) and the Medicines and Healthcare products Regulatory Agency (MHRA), before carrying out a human fetal gene therapy trial. Charles Coutelle said: 'We would like another five years to make decisions about which diseases and which vector [gene delivery system] to choose, so we can do all the necessary safety tests we and the regulatory bodies think are required'.

A 1998 GTAC report on gene therapy in utero said that this approach did not raise any new ethical issues, compared to other medical treatments carried out in the womb, or the use of gene therapy in other situations. However, GTAC cautioned that existing concerns over the potential for germ-line transmission (the genetic alteration of egg or sperm-producing cells) remain. 'Such concerns would need to be fully answered in the event of any protocols proposing in utero gene therapy being presented to GTAC', the report concluded.


Dr Jess Buxton is Contributing Editor at BioNews and a Trustee at the charity that publishes it, the Progress Educational Trust (PET). She is co-author of The Rough Guide to Genes and Cloning (buy this book from Amazon UK) and Human Fertilisation and Embryology: Reproducing Regulation (buy this book from Amazon UK).

SOURCES & REFERENCES
The Daily Telegraph | 30 March 2004
 
BBC News Online | 30 March 2004
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

19 October 2015 - by Dr Jane Currie 
Researchers have announced the first clinical trial of stem-cell therapy for fetuses still in the womb, as a treatment for brittle bone disease...

29 March 2004 - by BioNews 
Gene therapy trials for haemophilia, muscular dystrophy and childhood blindness are to receive £3 million funding, the UK Department of Health has announced. A further £1 million has been set aside for research into the long-term safety of some gene therapy techniques. The funding is part of a £50 million...
18 February 2002 - by BioNews 
Doctors have successfully used gene therapy in the treatment for a type of haemophilia, a condition caused by a defect in one of the genes which controls blood clotting. Sufferers bruise easily, are prone to nosebleeds, and have a risk of internal bleeding. A virus that had been genetically altered...
06 March 2000 - by BioNews 
Two patients in a gene therapy trial for haemophilia, a blood-clotting disorder, have shown a marked improvement in their condition. The US team, from Stanford University School of Medicine and the Children's Hospital of Philadelphia, admit they were surprised by the results, which are published in this month's Nature Genetics...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation